Long-term outlooks remain bullish but traders are not ruling out more pain first.
Bitcoin, BTC priceRead More
You might also be interested in reading Catalyst Pharmaceuticals up 5% on 2025 revenue guidance.
Long-term outlooks remain bullish but traders are not ruling out more pain first.
Bitcoin, BTC priceRead More
You might also be interested in reading Catalyst Pharmaceuticals up 5% on 2025 revenue guidance.